Arcus Biosciences (RCUS) Change in Acquisitions & Divestments (2017 - 2026)

Arcus Biosciences' Change in Acquisitions & Divestments history runs 10 years deep, the most recent figure standing at $257.0 million for Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments fell 28.61% year-over-year to $257.0 million; the TTM figure through Mar 2026 stood at $970.0 million (down 9.09% YoY), while the FY2025 annual figure was $1.1 billion, up 15.5% from the prior year.
• Change in Acquisitions & Divestments for Q1 2026 stood at $257.0 million, up from $215.0 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $360.0 million in Q1 2025, with the low at $94.0 million in Q1 2022.
• The 5-year median for Change in Acquisitions & Divestments is $242.0 million (2024), against an average of $231.5 million.
• The sharpest annual moves came in 2022 and 2023: Change in Acquisitions & Divestments slumped 62.6% in 2022, then soared 202.13% in 2023.
• Arcus Biosciences' Change in Acquisitions & Divestments stood at $203.0 million in 2022, then retreated by 28.57% to $145.0 million in 2023, then jumped by 40.0% to $203.0 million in 2024, then gained by 5.91% to $215.0 million in 2025, then advanced by 19.53% to $257.0 million in 2026.
• Business Quant data shows RCUS's Change in Acquisitions & Divestments at $257.0 million in Q1 2026, $215.0 million in Q4 2025, and $243.0 million in Q3 2025.